2020
Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study
Grilo CM, Lydecker JA, Morgan PT, Gueorguieva R. Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study. Clinical Therapeutics 2020, 43: 112-122.e1. PMID: 33218742, PMCID: PMC7902424, DOI: 10.1016/j.clinthera.2020.10.010.Peer-Reviewed Original ResearchConceptsBinge-eating disorderEating-disorder psychopathologyPilot RCTTreatment of BEDOutcome time pointDouble-blind treatmentPercentage of patientsControlled Pilot StudyDiscontinuation of medicationTreatment of bingeEvidence-based treatmentsBinge-eating frequencyBupropion combinationAdult patientsAdverse eventsComorbid obesitySecondary outcomesPrimary outcomeAcute effectsFunctional impairmentPlaceboLong-term effectsPatientsMost outcomesObesity
2015
A novel approach to training students in delivering evidence-based obesity treatment.
Brown J, Lydecker JA, Turner T, Knackstedt RW, O'Neil PM. A novel approach to training students in delivering evidence-based obesity treatment. Family Medicine 2015, 47: 378-82. PMID: 25905881.Peer-Reviewed Original ResearchConceptsHealth care studentsCare studentsEvidence-based obesity treatmentInterprofessional health care studentsMajor public health concernLow-income overweightWeight management professionalsWeight management interventionsService-learning componentService-learning opportunitiesService-learning programEvidence-based treatmentsHealth care providersPublic health concernSerious health consequencesPatient weightObesity treatmentAddress obesityStudents' deliveryExperiential learningCare providersTraining studentsEducational curriculumDidactic instructionObesity